Why this matters — Three distinct ORTEX data streams have converged on EUDA (EUDA Health Holdings Limited) within days. Short interest, cost to borrow, and utilisation have all hit extreme levels simultaneously — a rare triple-signal alignment.
Short interest surge. Short shares stood at roughly 2,900 on April 22. By April 24 they hit 163,180 — a 2,702% weekly explosion. The single-day jump on April 23 alone was 2,518%. This is not a gradual build; it is an abrupt, concentrated positioning event.
Cost to borrow at extreme levels. Borrow costs hit 355.9% APR on April 24. That is up 103% in one week and up 249% over the past month. As recently as early March, CTB sat below 90%. The near-fourfold rise signals acute scarcity of lendable shares.
Utilisation hits 52-week high. SI utilisation reached 93.44% on April 24 — the highest reading in 52 weeks. As recently as April 7 it was 22.5%. The inventory of borrowable shares is now almost fully deployed.
Factor scores reinforce the picture. EUDA ranks in the 3rd percentile on utilisation and the on short score rank — placing it among the most heavily borrowed names in the universe. The ORTEX short score rose to 68.8 on April 23, up from 54.8 on April 10. The combined ORTEX score stands at 79.5.
EUDA saw a comparable short-interest spike in mid-to-late March 2026. Shares short briefly exceeded 249,000 on March 20 before collapsing back to under 3,000 by April 6. Cost to borrow was lower during that episode. The current build is starting from a much lower base but is accelerating faster.
See the live data behind this article on ORTEX.
Open EUDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
